France’s REEV raises €8.8M to transform mobility assistance with wearable robotics

By Vigneshwar Ravichandran

Toulouse, France-based REEV, a medtech startup developing intelligent, lightweight wearable robotics, announced that it has raised a $9.2M (approximately €8.8M) funding round. The latest funding round was led by Newfund Heka, Polytechnique Ventures, and Irdi Capital, with additional support from Techstars and a group of business angels and healthcare operators. Newfund is an early-stage VC that supports entrepreneurs driving disruptive innovation across all sectors, with a particular focus on those with international ambitions. The fund invests seed capital to help initiate international expansion and continues to support entrepreneurs over the long term through follow-on investments.

“We are proud to continue supporting REEV as they work toward FDA clearance to bring their technology to market in the U.S. This marks a key milestone in improving mobility for neurological patients,” says Anne-Sophie Saint-Martin, Partner at Newfund. Additional contributors include French soccer player Raphael Varane and knee surgeon Herve Silbert, assembled by Scala Patrimoine, a multi-family office.

Fund utilisation

The French company will use the funds to finalise DREEVEN’s design. Additionally, they will conduct a clinical study at the Neuromotor Recovery Lab at Boston University’s Sargent College of Health & Rehabilitation Sciences under the leadership of Dr. Lou Awad. Finally, the company will use the capital to prepare for the trials required by the U.S. Food and Drug Administration.

“We are thrilled to enter the next phase of clinical and industrial development,” says Amaury Ciurana, Co-Founder and CEO of REEV. “Our innovative technologies, like the DREEVEN motorised orthosis, aim to redefine mobility assistance, transforming lives and reshaping the orthotics industry.”

REEV: Restoring mobility freedom

Founded in 2021 by Amaury Ciurana (CEO) and Dr. Robin Temporelli (CTO), REEV is on a mission to help millions with walking disorders overcome their disabilities by becoming more autonomous and independent in their daily movements. The company does this by developing intelligent wearable robotics that restores mobility freedom, providing lightweight and intuitive assistance to walk, stand, sit, and climb stairs easily and confidently. Currently, the company’s technology portfolio includes: REEV SENSE – A motion sensor system that attaches to a patient’s shoe or leg, delivering precise gait analysis. DREEVEN – A wearable robotics system using electro-hydraulic technology to provide personalized knee assistance.

The company aims to address limitations in existing exoskeleton technologies by reducing device weight, lowering costs, and enhancing personalization. The company has already started initial testing of DREEVEN functional units with patients. The first DREEVEN series is expected to launch in 2026.

France’s REEV raises €8.8M to transform mobility assistance with wearable robotics

Toulouse-based REEV, a medtech startup developing intelligent, lightweight wearable robotics, announced a $9.2M ($8.8M) funding round. Newfund Heka, Polytechnique Ventures, and Irdi Capital led the round, with Techstars and business angels and healthcare operators providing additional support. REev will use the funds to finalize their design, conduct a clinical study at Boston University's Sargent College, and prepare for the U.S. Food and Drug Administration trials. The company aims to restore mobility freedom for millions with walking disorders by providing lightweight and intuitive assistance.